How do we choose a therapeutic regimen in cystic fibrosis?

Robertson, C. F.
October 2002
Thorax;Oct2002, Vol. 57 Issue 10, p839
Academic Journal
As the range of treatments for cystic fibrosis increases and the costs rise, the clinician is faced with an increasingly complex dilemma to develop a treatment schedule that provides optimal benefit, given financial restraints and the impact of an increasingly complex therapeutic regimen on patient adherence.


Related Articles

  • Electrodiffusional ATP movement through CFTR and other ABC transporters. Cantiello, H. F. // Pflugers Archiv European Journal of Physiology;Nov2001 Supplement 1, Vol. 443, pS22 

    The cystic fibrosis transmembrane conductance regulator (CFTR) is a member of the superfamily of ATP-binding cassette (ABC) transporters, also known as traffic ATPases. Recent studies from our laboratory determined that various members of the ABC family of transport proteins mediate the...

  • Effect of acute saline volume expansion in the anaesthetised ΔF508 cystic fibrosis mouse. Kibble, Jonathan D.; Neal, Andrew; Green, Roger; Colledge, William H.; Taylor, Christopher J. // Pflugers Archiv European Journal of Physiology;Nov2001 Supplement 1, Vol. 443, pS17 

    It has been suggested that CFTR Cl– channels in the renal inner medullary collecting duct may be involved in mediating increased renal salt excretion during extracellular fluid volume expansion. To investigate this hypothesis, in-vivo clearance experiments were performed comparing...

  • Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7. Shori, D. K.; Genter, T.; Hansen, J.; Koch, C.; Wyatt, H.; Kariyawasam, H. H.; Knight, R. A.; Hodson, M. E.; Kalogeridis, A.; Tsanakas, I. // Pflugers Archiv European Journal of Physiology;Nov2001 Supplement 1, Vol. 443, pS55 

    Destruction of the lungs as a consequence of recurrent infections with microorganisms such as Pseudomonas aeruginosa remains the underlying cause of most morbidity and mortality in cystic fibrosis (CF). We have hypothesized that changes in the glycosylation of key tracheal mucins such as MUC5B...

  • Sulphation of the salivary mucin MG1 (MUC-5B) is not correlated to the degree of its sialylation and is unaffected by cystic fibrosis. Shori, D. K.; Kariyawasam, H. H.; Knight, R. A.; Hodson, M. E.; Genter, T.; Hansen, J.; Koch, C.; Kalogeridis, A. // Pflugers Archiv European Journal of Physiology;Nov2001 Supplement 1, Vol. 443, pS50 

    Defective acidification of intracellular organelles, particularly the trans-Golgi network, has been proposed to explain the decreased sialylation and increased sulphation of secreted proteins in cystic fibrosis (CF). To test this hypothesis we compared expression of sulphate and sialic acid on...

  • Cystic Fibrosis.  // Encyclopedic Reference of Molecular Pharmacology;2004, p284 

    A reference entry for "cystic fibrosis" is presented. It refers to a common autosomal recessive disorder caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator protein. Main symptoms include a progressive obstructive lung disease and pancreatic...

  • CFTR allelic heterogeneity in Brazil: historical and geographical perspectives and implications for screening and counseling for cystic fibrosis in this country. Faucz, Fabio R.; Souza, Denise A. S.; Olandoski, Marcia; Raskin, Salmo // Journal of Human Genetics;Feb2010, Vol. 55 Issue 2, p71 

    The goal of the present study was to provide a complete and updated spectrum of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) gene mutations in the Brazilian population combining all available in silico data for patients with CF in Brazil, including founder background and...

  • Mycobacterium abscessus and Children with Cystic Fibrosis. Sermet-Gaudelus, Isabelle; Le Bourgeois, Muriel; Pierre-Audigier, Catherine; Offredo, Catherine; Guillemot, Didier; Halley, Sophie; Akoua-Koffi, Chantal; Vincent, Véronique; Sivadon-Tardy, Valérie; Ferroni, Agnès; Berche, Patrick; Scheinmann, Pierre; Lenoir, Gérard; Gaillard, Jean-Louis // Emerging Infectious Diseases;Dec2003, Vol. 9 Issue 12, p1587 

    We prospectively studied 298 patients with cystic fibrosis (mean age 11.3 years; range 2 months to 32 years; sex ratio, 0.47) for nontuberculous mycobacteria in respiratory samples from January 1, 1996, to December 31, 1999. Mycobacterium abscessus was by far the most prevalent nontuberculous...

  • Cystic fibrosis: addressing the transition from pediatric to adult-oriented health care. Kreindler, James L.; Miller, Victoria A. // Patient Preference & Adherence;2013, Vol. 7, p1221 

    Survival for patients with cystic fibrosis (CF) increased to nearly 40 years in 2012 from the early childhood years in the 1940s. Therefore, patients are living long enough to require transition from pediatric CF centers to adult CF centers. The goal of transition is for the young adult to be...

  • Making sense of the CF screening guidelines. Simpson, Joe Leigh // Contemporary OB/GYN;Oct2004, Vol. 49 Issue 10, p60 

    Provides practical advice on how to individualize the guidelines on cystic fibrosis screening. Pathogenesis and prevalence of the autosomal-recessive disorder; Signs and symptoms of cystic fibrosis; Identification of the genetic mutation that cause cystic fibrosis. INSET: Take-home messages.


Read the Article


Sign out of this library

Other Topics